Abvc Biopharma (ABVC) Land & Improvements (2021 - 2026)

Abvc Biopharma (ABVC) has 5 years of Land & Improvements data on file, last reported at $5.0 million in Q1 2026.

• Quarterly Land & Improvements rose 1395.97% year-over-year to $5.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $5.0 million (up 1395.97% YoY) and the FY2025 annual result came in at $4.2 million, up 1145.37% from the prior year.
• Land & Improvements improved to $5.0 million in Q1 2026, from $4.2 million in the prior quarter.
• In the past five years, Land & Improvements ranged from a high of $5.0 million in Q1 2026 to a low of $334520.0 in Q1 2025.
• A 4-year average of $2.1 million and a median of $378975.0 in 2025 frame the typical range for Land & Improvements.
• Annual changes were most pronounced in 2022 — Land & Improvements decreased 9.72% — and 2026, when it soared 1395.97%.
• Tracing ABVC's Land & Improvements over 4 years: stood at $361193.0 in 2022, then dropped by 6.15% to $338966.0 in 2024, then surged by 1145.37% to $4.2 million in 2025, then gained by 18.55% to $5.0 million in 2026.
• The last three Land & Improvements figures came in at $5.0 million (Q1 2026), $4.2 million (Q4 2025), and $4.2 million (Q3 2025), per Business Quant data.